U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell-based therapeutics products. The company’s lead product MyoCell is an autologous muscle stem cell therapy for improving cardiac functions of a patient with serious, chronic heart damage due to heart attack. Its other lead product is MyoCell SDF-1, an improvement of MyoCell for similar applications; AdipoCell, a proprietary kit used for the isolation of adipose (fat) derived stem cells. The company provides laboratory services, regenerative medicine and cell therapy training services, the sale of cell collection and treatment kits for human and animals and operates a cell therapy clinic. The company primarily operates in the US and sales its products to non-US countries as well. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.